Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19182602 | Cosmetic Formulation | April 2025 | August 2025 | Allow | 4 | 1 | 0 | No | No |
| 18428005 | COMPLEXES OF WHEY PROTEIN MICELLES AND PECTIN AND BODY MUSCLE PROTEIN SYNTHESIS | January 2024 | March 2026 | Abandon | 25 | 2 | 0 | No | Yes |
| 18525495 | SOLID HAND AND BODY LOTION PELLETS | November 2023 | August 2024 | Abandon | 8 | 1 | 0 | No | No |
| 18504280 | AQUEOUS ORAL COMPOSITIONS INCLUDING POTASSIUM CHLORIDE | November 2023 | December 2025 | Allow | 25 | 3 | 0 | No | No |
| 18260963 | PREPARATION OF A TINTED COSMETIC COMPOSITION | July 2023 | February 2026 | Abandon | 31 | 0 | 1 | No | No |
| 18199345 | COMPOSITE PARTICLES, METHOD OF PRODUCING COMPOSITE PARTICLES AND DRY POWDER OF COMPOSITE PARTICLES, SKIN APPLICATION COMPOSITION AND METHOD OF PRODUCING THE SKIN APPLICATION COMPOSITION | May 2023 | December 2025 | Abandon | 31 | 1 | 1 | No | No |
| 18139095 | TABLET CONTAINING VALSARTAN AND SACUBITRIL | April 2023 | December 2024 | Abandon | 20 | 1 | 1 | Yes | No |
| 18302726 | DELIVERY OF COSMETIC AGENTS, COMPOSITIONS AND USE THEREOF | April 2023 | April 2025 | Abandon | 24 | 2 | 0 | No | No |
| 18026633 | MOISTURIZING ANTIBACTERIAL COMPOSITION | March 2023 | May 2025 | Abandon | 26 | 4 | 1 | No | No |
| 18026658 | MOISTURIZING ANTIBACTERIAL COMPOSITION | March 2023 | May 2025 | Abandon | 26 | 4 | 1 | No | No |
| 18024281 | SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING MICRONIZED TRIS-BIPHENYL TRIAZINE | March 2023 | December 2025 | Abandon | 33 | 0 | 1 | No | No |
| 18017734 | COSMETIC MASK FOR IMPROVING APPEARANCE OF SKIN | January 2023 | November 2024 | Abandon | 21 | 2 | 1 | No | No |
| 18155677 | GADUSOL-CONTAINING SUNSCREEN FORMULATIONS | January 2023 | September 2024 | Abandon | 20 | 2 | 1 | Yes | No |
| 17928327 | A PERSONAL CARE COMPOSITION BASED ON TITANIUM OXIDE AND A CROSSPOLYMER OF ADIPIC ACID AND NEOPENTYL GLYCOL | November 2022 | March 2026 | Abandon | 39 | 1 | 1 | No | No |
| 18057777 | PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS BLENDS OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS | November 2022 | November 2025 | Abandon | 35 | 3 | 1 | No | Yes |
| 17975284 | ANHYDROUS COSMETIC CONCEALER COMPOSITIONS HAVING LOW FILLER LEVELS | October 2022 | August 2025 | Abandon | 34 | 5 | 1 | No | No |
| 17823939 | GADUSOL-CONTAINING SUNSCREEN FORMULATIONS | August 2022 | October 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17865229 | Exosome-based Skincare Product | July 2022 | November 2023 | Allow | 16 | 1 | 0 | No | No |
| 17791703 | COSMETIC COMPOSITION | July 2022 | February 2026 | Abandon | 43 | 1 | 1 | No | No |
| 17848269 | SALINE-BASED NASAL TREATMENT COMPOSITION | June 2022 | September 2023 | Allow | 15 | 1 | 0 | No | No |
| 17842609 | Sunscreen Composition | June 2022 | February 2025 | Abandon | 32 | 3 | 0 | No | No |
| 17777726 | HAIR CARE COMPOSITION | May 2022 | October 2025 | Abandon | 41 | 1 | 1 | No | No |
| 17773611 | TREATMENT OF TOOTH DECAY USING A CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS | May 2022 | June 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17660499 | AQUEOUS ORAL COMPOSITIONS INCLUDING POTASSIUM CHLORIDE | April 2022 | November 2023 | Abandon | 19 | 1 | 0 | No | No |
| 17770963 | Fighting Against Varroa Parasite in Beekeeping Using a Natural Formulation Comprising Essential Oils and Wood Vinegar | April 2022 | April 2025 | Allow | 36 | 2 | 0 | No | No |
| 17764625 | PRESSURE-SENSITIVE ADHESIVE MATRIX AND PATCH | March 2022 | March 2026 | Abandon | 47 | 3 | 1 | No | No |
| 17694367 | HYBRID NAIL COATING SYSTEMS AND METHODS OF THEIR USE | March 2022 | July 2024 | Abandon | 28 | 2 | 0 | No | No |
| 17692686 | ANHYDROUS SKIN CARE COMPOSITION COMPRISING RETINOL AND/OR BAKUCHIOL | March 2022 | December 2025 | Abandon | 45 | 5 | 1 | No | No |
| 17649674 | COSMETIC COMPOSITIONS | February 2022 | September 2024 | Abandon | 31 | 2 | 0 | No | No |
| 17631853 | PHOTOCURABLE COMPOSITION | January 2022 | September 2025 | Abandon | 43 | 1 | 1 | No | No |
| 17581322 | BIODEGRADABLE POLYMER MICROPARTICLE FOR FILLER, MANUFACTURING METHOD THEREOF, FREEZE-DRIED BODY INCLUDING THE SAME, AND FILLER INJECTION INCLUDING THE SAME | January 2022 | December 2022 | Allow | 11 | 1 | 1 | No | No |
| 17626116 | SOLID HAIR CONDITIONING COMPOSITIONS | January 2022 | June 2025 | Abandon | 42 | 2 | 1 | No | No |
| 17624287 | COMPOSITION FOR TREATING AND PREVENTING BACTERIAL GROWTH ON A SUBSTRATE | December 2021 | October 2025 | Abandon | 46 | 2 | 1 | No | No |
| 17565441 | WATER-SOLUBILIZED MIXTURE OF GINSENOSIDE COMPOUND K AND METHOD OF WATERSOLUBILIZING GINSENOSIDE COMPOUND K | December 2021 | November 2023 | Abandon | 22 | 1 | 0 | No | No |
| 17559447 | Flexible Gelatin Sealant Dressing with Reactive Components | December 2021 | June 2024 | Abandon | 29 | 3 | 0 | No | No |
| 17549131 | HEMOSTATIC COMPOSITIONS AND METHODS OF MAKING THEREOF | December 2021 | January 2024 | Allow | 25 | 2 | 0 | No | No |
| 17543503 | CATALYTIC SYSTEMS INCLUDING A PEROXIDE FOR DELIVERY OF OXYGEN TO SKIN AND RELATED METHODS OF USE | December 2021 | December 2025 | Abandon | 48 | 6 | 0 | Yes | No |
| 17616511 | PARTICLE-CONTAINING COMPOSITION | December 2021 | August 2023 | Abandon | 21 | 2 | 1 | Yes | No |
| 17608937 | TOPICAL COMPOSITIONS | November 2021 | March 2025 | Abandon | 41 | 1 | 1 | No | No |
| 17607642 | DENTAL ROOT CANAL FILLING MATERIAL COMPOSITION | October 2021 | December 2025 | Abandon | 49 | 2 | 1 | No | No |
| 17607654 | HAIR DYEING METHOD | October 2021 | January 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17606443 | NUTRIENT SOLUTION FORMULA FOR INHIBITING GREEN ALGAE | October 2021 | October 2024 | Allow | 36 | 1 | 0 | No | No |
| 17604638 | Antifungal Wallboards | October 2021 | March 2025 | Abandon | 41 | 1 | 1 | No | No |
| 17485891 | STABLE LIQUID COMPOSITIONS OF PEMETREXED | September 2021 | July 2024 | Abandon | 33 | 2 | 1 | No | No |
| 17482003 | Compound and Composition for Use in the Preventive and/or Curative Treatment of Diseases of the Central Nervous System Characterised by a Decline in Neuronal Plasticity, in Particular Characterised by a Decline in Synaptic Plasticity | September 2021 | May 2024 | Abandon | 32 | 3 | 0 | No | No |
| 17441869 | SURFACE-MODIFIED DOPED TITANIUM DIOXIDE NANOPARTICLES AND USES | September 2021 | August 2025 | Abandon | 47 | 2 | 1 | No | No |
| 17476716 | METHOD FOR DRY POWDER COATING CAPSULES | September 2021 | September 2023 | Abandon | 24 | 0 | 1 | No | No |
| 17440124 | EXTENDED RELEASE COMPOSITION OF TOFACITINIB | September 2021 | December 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17438735 | COMPOSITIONS AND METHODS FOR 3D PRINTED FIBROUS SCAFFOLDS WITH ANTIMICROBIAL PROPERTIES INCORPORATING GRAPHENE OXIDE AND POLY(E-CAPROLACTONE) | September 2021 | February 2025 | Abandon | 41 | 1 | 1 | No | No |
| 17433919 | PATCH | August 2021 | February 2025 | Abandon | 41 | 2 | 0 | No | No |
| 17264152 | GINKGO BILOBA LEAVE EXTRACT CAPSULE AND PREPARATION METHOD THEREFOR | August 2021 | May 2025 | Allow | 51 | 2 | 1 | No | No |
| 17433424 | ANTIMICROBIAL DRESSING, DRESSING COMPONENTS, AND METHODS | August 2021 | April 2025 | Abandon | 44 | 2 | 1 | No | No |
| 17401722 | HAIR TREATMENT COMPOSITIONS PROVIDING BRIGHTENING AND SHINE | August 2021 | February 2026 | Abandon | 54 | 4 | 1 | Yes | Yes |
| 17400396 | BIOFLAVONOID IMPREGNATED MATERIALS | August 2021 | October 2023 | Abandon | 26 | 1 | 1 | No | No |
| 17387812 | Composition for treating diabetes based on traditional Chinese medicine nutritional therapy and application thereof | July 2021 | June 2025 | Abandon | 47 | 2 | 1 | No | No |
| 17425969 | A COMPOSITE AND A METHOD OF PREPARING THE SAME | July 2021 | November 2025 | Abandon | 52 | 4 | 1 | No | No |
| 17421916 | RAPIDLY DISINTEGRATING ORAL TABLET | July 2021 | October 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17420182 | SUSTAINED-RELEASE INJECTION FORMULATION COMPRISING CONJUGATE OF POLY-L-LACTIC ACID FILLER AND HYALURONIC ACID FILLER AND BIOACTIVE MATERIALS, AND PREPARATION METHOD THEREOF | July 2021 | June 2024 | Allow | 36 | 1 | 0 | No | No |
| 17364081 | BIODEGRADABLE SINGLE-PHASE COHESIVE HYDROGELS | June 2021 | July 2024 | Abandon | 37 | 2 | 1 | No | No |
| 17350268 | TABLET CONTAINING FERRIC CITRATE | June 2021 | May 2023 | Abandon | 23 | 0 | 1 | No | No |
| 17413390 | BERBERINE/MINERALIZED COLLAGEN-BASED COMPOSITE MEMBRANE AND PREPARATION METHOD AND APPLICATION THEREOF | June 2021 | April 2024 | Allow | 34 | 1 | 0 | No | No |
| 17312979 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ADMINISTRATION OF MESALAZINE OR DERIVATIVES THEREOF | June 2021 | February 2025 | Abandon | 44 | 1 | 1 | No | No |
| 17315557 | USE OF HYDROXYAPATITE AS A CARRIER OF BIOACTIVE SUBSTANCES FOR TREATING VASCULAR DISEASES IN PLANTS | May 2021 | June 2023 | Allow | 26 | 0 | 0 | No | No |
| 17302428 | ANTIVIRAL PREPARATION FOR TREATING HUMAN SKIN | May 2021 | October 2023 | Abandon | 29 | 1 | 1 | No | No |
| 17290670 | HAIR COSMETIC AND HAIR TREATMENT METHOD USING SAME | April 2021 | December 2024 | Abandon | 43 | 2 | 1 | No | No |
| 17285709 | METHOD FOR PRODUCING COATING FILM | April 2021 | July 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17218797 | PRESERVATIVE SYSTEM | March 2021 | June 2025 | Abandon | 51 | 8 | 1 | No | No |
| 17216128 | Skin Protecting Cosmetic Concealer Ointment | March 2021 | July 2024 | Abandon | 40 | 3 | 0 | No | No |
| 17189768 | Mattifying Cosmetic Compositions | March 2021 | February 2023 | Abandon | 24 | 1 | 0 | No | No |
| 17187882 | Delivery Of Cosmetic Agents, Compositions And Use Thereof | March 2021 | February 2024 | Abandon | 36 | 3 | 1 | No | No |
| 17270604 | Folded Porous Ingrowth Features for Medical Implants | February 2021 | June 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17268620 | Oil-Based Solid Cosmetic | February 2021 | February 2025 | Allow | 48 | 6 | 1 | Yes | No |
| 17167282 | BIOFLAVONOID IMPREGNATED MATERIALS | February 2021 | February 2025 | Abandon | 49 | 4 | 1 | No | No |
| 17159574 | MASCARA COMPOSITION AND METHOD OF USE | January 2021 | June 2024 | Abandon | 41 | 3 | 1 | No | No |
| 17262436 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | January 2021 | May 2025 | Abandon | 52 | 2 | 0 | No | Yes |
| 17154842 | SKINCARE COMPOSITIONS INCLUDING ZINC OXIDE | January 2021 | August 2022 | Allow | 19 | 1 | 0 | No | No |
| 17250410 | Personal Care Compositions and Methods for the Same | January 2021 | February 2025 | Abandon | 48 | 3 | 1 | No | No |
| 17146356 | METHOD FOR PROMOTING HOMEOSTASIS IN THE SKIN | January 2021 | June 2023 | Abandon | 29 | 2 | 0 | No | No |
| 17144533 | METHOD AND SYSTEM FOR REMOVING MAKEUP | January 2021 | April 2025 | Abandon | 51 | 8 | 1 | No | No |
| 17137370 | EYELASH LIQUID EYELINER | December 2020 | April 2022 | Allow | 15 | 0 | 0 | No | No |
| 17251015 | FLOWABLE CANNABINOID COMPOSITIONS HAVING HIGH EFFECTIVE CONCENTRATIONS | December 2020 | March 2024 | Abandon | 39 | 1 | 0 | No | No |
| 16972431 | COMPOSITION FOR DYEING | December 2020 | June 2023 | Abandon | 30 | 2 | 1 | Yes | No |
| 16981104 | MASSAGE CANDLE CONTAINING CANNABIDIOL OR ESSENTIAL OIL | December 2020 | December 2024 | Abandon | 51 | 4 | 0 | No | No |
| 16972219 | OIL-IN-WATER TYPE EMULSION COSMETIC USING PARTIALLY CROSSLINKED OR CROSSLINKED DIMETHYLPOLYSILOXANE | December 2020 | June 2024 | Abandon | 42 | 4 | 0 | No | No |
| 17109160 | PUMPKIN SEED PROTEIN NANOPARTICLES, METHODS FOR PREPARING AND USING THEREOF | December 2020 | June 2022 | Allow | 18 | 1 | 0 | No | No |
| 16952370 | ALCOHOL-BASED SPRAYABLE GEL WITH YIELD POINT | November 2020 | November 2023 | Abandon | 36 | 3 | 0 | No | No |
| 16952083 | METHOD FOR PRODUCING SOLID POWDER COSMETIC | November 2020 | May 2023 | Abandon | 30 | 3 | 0 | No | No |
| 16766966 | METHOD FOR PRODUCING COSMETIC COMPOSITION COMPRISING NATURAL PLANT AND COSMETIC COMPOSITION PRODUCED THEREBY | November 2020 | June 2025 | Abandon | 60 | 4 | 1 | Yes | No |
| 16949647 | MASCARA FORMULATION | November 2020 | December 2022 | Abandon | 25 | 1 | 0 | No | No |
| 17091166 | SKIN CARE COMPOSITIONS AND METHODS FOR MAKING THE SAME | November 2020 | January 2023 | Abandon | 27 | 1 | 1 | No | No |
| 17048432 | POWDEROUS COMPOSITION COMPRISING CAROTENOID AND/OR DERIVATIVE THEREOF, D-GLYCOSE OLIGOMERS AND MODIFIED POLYSACCHARIDE AS WELL AS FOOD, FEED OR PERSONAL CARE FORMULATION COMPRISING THE COMPOSITION | October 2020 | May 2024 | Abandon | 43 | 2 | 0 | No | No |
| 17046860 | THICK WATER-BASED COSMETIC | October 2020 | July 2024 | Abandon | 45 | 4 | 0 | Yes | No |
| 17060191 | Sincalide Formulations | October 2020 | July 2022 | Abandon | 21 | 1 | 0 | No | No |
| 17038943 | HYDRATING NO-RINSE COMPOSITION FOR MAKEUP REMOVAL | September 2020 | June 2025 | Abandon | 56 | 5 | 1 | Yes | No |
| 17031546 | ANTIBACTERIAL ACTIVITY BY MG COMPLEX IN DEODORANT EMULSION FOR AEROSOLS, DEODORANT INCLUDING THE SAME AND USE OF THE DEODORANT | September 2020 | July 2022 | Abandon | 21 | 1 | 0 | No | No |
| 17040208 | 3D PRINTING COMPOSITION FOR BIOMATERIALS | September 2020 | December 2025 | Abandon | 60 | 3 | 1 | Yes | No |
| 16980435 | COMPOSITION FOR PURIFICATION OF BIOFLUIDS | September 2020 | October 2024 | Abandon | 49 | 2 | 1 | Yes | No |
| 16979375 | WATER-RESISTANT COSMETIC COMPOSITION | September 2020 | August 2023 | Abandon | 36 | 4 | 1 | No | No |
| 17013541 | NAIL COATING REMOVER CREAM MASK AND THE METHOD OF USING THEREOF | September 2020 | September 2022 | Abandon | 24 | 3 | 1 | Yes | No |
| 17010121 | COMPOSITE PARTICLES, METHOD OF PRODUCING COMPOSITE PARTICLES AND DRY POWDER OF COMPOSITE PARTICLES, SKIN APPLICATION COMPOSITION AND METHOD OF PRODUCING THE SKIN APPLICATION COMPOSITION | September 2020 | April 2024 | Abandon | 43 | 6 | 1 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PROSSER, ALISSA J.
With a 14.6% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 8.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner PROSSER, ALISSA J works in Art Unit 1619 and has examined 483 patent applications in our dataset. With an allowance rate of 16.4%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.
Examiner PROSSER, ALISSA J's allowance rate of 16.4% places them in the 2% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by PROSSER, ALISSA J receive 3.22 office actions before reaching final disposition. This places the examiner in the 90% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by PROSSER, ALISSA J is 36 months. This places the examiner in the 34% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +13.8% benefit to allowance rate for applications examined by PROSSER, ALISSA J. This interview benefit is in the 52% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 3.2% of applications are subsequently allowed. This success rate is in the 2% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 11.1% of cases where such amendments are filed. This entry rate is in the 11% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 40.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 36% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 32.8% of appeals filed. This is in the 4% percentile among all examiners. Of these withdrawals, 45.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 84.8% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.4% of allowed cases (in the 59% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 1% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.